Delving into the Latest Updates on Accelerated Medical Diagnostics LLC with Synapse

Overview

Accelerated Medical Diagnostics LLC is developing a diagnostics test for cancer patients.Our mission is to predict cancer patient response to platinum-based drugs prior to initiation of chemotherapy.The test, called PlatinDx, features administration of a microdose (1% of the therapeutic dose) of chemotherapy, followed by mass spectrometry anal. of blood and tumor biopsy samples for the presence of drug-DNA adducts, whose concentration in patient tissues correlates with response to therapy.PlatinDx is currently entering multicenter clin. studies with the goal of obtaining FDA clearance.In addition to discussing our technol., we will discuss the reasons for and process of founding Accelerated Medical Diagnostics LLC as a spin-off from University of California-Davis and Lawrence Livermore National Laboratory, including our business model, SBIR funding, and some of the challenges, successes, and failures that we have encountered to date.

100 Deals associated with Accelerated Medical Diagnostics LLC

Login to view more data

100 Translational Medicine associated with Accelerated Medical Diagnostics LLC

Login to view more data